The earliest development of neutralising antibodies was seen in 2 out of 67 subjects (3%) 6-9 months after the start of NeuroBloc treatment.
Kõige varem täheldati neutraliseerivate antikehade teket 2 (3%) isikul 67- st 6– 9 kuu möödudes NeuroBloc- ravi algusest.